The impact of radiotherapy on the heart has become an area of interest in recent years.
Many different cardiac dose-volume constraints have been associated with cardiac toxicity …

Introduction Inter‐observer variability (IOV) in target volume and organ‐at‐risk (OAR)
delineation is a source of potential error in radiation therapy treatment. The aims of this study …

Importance Radiotherapy accelerates coronary heart disease (CHD), but the dose to critical
cardiac substructures has not been systematically studied in lung cancer. Objective To …

Purpose A relationship between mean heart dose (MHD) and acute coronary event (ACE)
rate was reported in a study of patients with breast cancer (BC). The main objective of our …

Purpose The significance of radiotherapy (RT)–associated cardiac injury for stage III non–
small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with …

Purpose Radiation therapy is a critical component in the care of patients with non–small-cell
lung cancer (NSCLC), yet cardiac injury after treatment is a significant concern. Therefore …

Background: Radiotherapy-associated cardiac toxicity studies in patients with locally
advanced non–small cell lung cancer (NSCLC) have been limited by small sample size and …

Background and purpose Delineation of clinical target volumes (CTVs) is a weak link in
radiation therapy (RT), and large inter-observer variation is seen in breast cancer patients …

Background and purpose The heart is a complex anatomical organ and contouring the
cardiac substructures is challenging. This study presents a reproducible method for …

Background: Hodgkin lymphoma (HL) survivors are at increased risk for develo** valvular
heart disease (VHD). We evaluated the determinants of the risk and the radiation dose …